FERRARI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.151
EU - Europa 804
AS - Asia 198
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.228
Nazione #
US - Stati Uniti d'America 1.150
GB - Regno Unito 259
IT - Italia 123
CN - Cina 118
DE - Germania 116
SE - Svezia 113
IE - Irlanda 47
IN - India 46
RU - Federazione Russa 39
FR - Francia 31
CI - Costa d'Avorio 26
ZA - Sudafrica 26
EE - Estonia 25
TG - Togo 20
CH - Svizzera 15
UA - Ucraina 14
VN - Vietnam 14
SG - Singapore 9
BE - Belgio 8
JO - Giordania 8
BG - Bulgaria 3
NL - Olanda 3
ES - Italia 2
EU - Europa 2
PL - Polonia 2
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
FI - Finlandia 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
LB - Libano 1
MU - Mauritius 1
Totale 2.228
Città #
Southend 246
Fairfield 168
Chandler 156
Ashburn 108
Woodbridge 96
Wilmington 77
Houston 68
Seattle 59
Ann Arbor 55
Princeton 52
Dublin 47
Cambridge 41
Padova 27
Abidjan 26
Nanjing 26
Westminster 25
Bremen 21
Dearborn 21
Turin 21
Lomé 20
Bologna 19
Boardman 18
Medford 15
Saint Petersburg 15
Bern 14
Nanchang 13
San Diego 12
Beijing 11
Falls Church 11
Berlin 9
Jinan 9
Amman 8
Brussels 8
Changsha 8
Hangzhou 8
Hebei 8
Catanzaro 6
Shenyang 6
Redwood City 5
Haikou 4
Jiaxing 4
Milan 4
Ningbo 4
Frattamaggiore 3
Moscow 3
Sofia 3
Taizhou 3
Tianjin 3
Wuppertal 3
Barcelona 2
Barletta 2
Bühl 2
Den Haag 2
Francavilla Al Mare 2
Frankfurt Am Main 2
Kilburn 2
Lanzhou 2
Naples 2
Napoli 2
Redmond 2
Singapore 2
Zhengzhou 2
Amsterdam 1
Bari 1
Brescia 1
Dhaka 1
Duncan 1
Falkenstein 1
Fontenay-sous-bois 1
Galatina 1
Guangzhou 1
Hanoi 1
Hefei 1
Helsinki 1
Hialeah 1
Landshut 1
Las Vegas 1
Los Angeles 1
Montereale 1
Mountain View 1
New Rochelle 1
Nichelino 1
Norwalk 1
Olalla 1
Olgiate Molgora 1
Omaha 1
Orange 1
Phoenix 1
Quispamsis 1
Riva 1
Rome 1
Santa Clara 1
Serra 1
Taiyuan 1
Tettnang 1
Tokyo 1
Walnut 1
Wuhan 1
Totale 1.659
Nome #
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 124
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 109
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age 108
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 104
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 101
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 98
Emerging therapeutic targets for synovial sarcoma 97
A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. 94
High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. 93
null 92
Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy. 89
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 89
Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. 86
Imaging in bone sarcomas. the chemotherapist's point of view 84
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 82
Periosteal osteosarcoma: a single-institution experience. 82
Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). 81
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS). 80
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 78
A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian sarcoma group (ISG) study. 75
International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study. 75
Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. 73
Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. 71
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 70
High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) 68
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma 43
MRgFUS new applications in musculoskeletal pathology: a miscellaneous case review 35
Totale 2.281
Categoria #
all - tutte 5.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020678 98 22 0 43 70 70 89 93 79 65 14 35
2020/2021233 62 27 7 4 5 7 0 18 26 11 13 53
2021/2022406 26 6 30 17 60 27 5 22 24 23 78 88
2022/2023581 58 90 27 76 47 41 23 31 112 14 26 36
2023/2024106 7 21 11 3 6 6 11 17 3 11 3 7
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 2.281